Search - tctmd.com

Displaying 41 - 60 of 672

Sort: Relevancy | Date

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

June 17, 2025

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

June 06, 2025

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

News Conference News ESOC 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

June 02, 2025

Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

News Conference News ESOC 2025

Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

May 28, 2025

Even Small Amounts of Exercise May Help Older Women Avoid Stroke

News Conference News ESOC 2025

Even Small Amounts of Exercise May Help Older Women Avoid Stroke

May 22, 2025

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

May 14, 2025

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

Donor Hearts Fare Better With Novel Method After Circulatory Death

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

April 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

April 18, 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

April 01, 2025

Risk of Another Event Remains High for Years After TIA, Minor Stroke

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

March 26, 2025

What’s Going to Be Hot at ACC 2025?

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Cannabis Use Again Tied to Increased CVD Risk in Young People

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

March 19, 2025

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

February 14, 2025

AHA Scientific Statement Takes Aim at PAD Pain

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

February 13, 2025

Electrical Brain Stimulation Fails to Improve Poststroke Recovery

News Conference News ISC 2025

Electrical Brain Stimulation Fails to Improve Poststroke Recovery

February 10, 2025

CVD Hospitalization in Older Adults Higher in US Than in Denmark

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.